Tenderwize
Retour à la recherche

Tocilizumab

Hospilim VZW·Diepenbeek, Belgium·Expired · Aug 10, 2026·Open·Supplies·Framework
Structured notice only
Titre original de l'avis

Belgium – Pharmaceutical products – Raamovereenkomst voor de levering van Tocilizumab

45/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkExpired
Pourquoi ce score ?

Opportunité

45 / 100

Complexité

40 / 100

Facteurs de risque

The estimated contract value is not disclosed. This makes it hard to evaluate the financial opportunity and bid prepara...

The tender is only in Dutch (NLD). Non-Dutch speaking suppliers may struggle to understand requirements and submit comp...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
Hospilim VZW
Pays
Belgique
CPV
33600000 - Pharmaceutical products +2 autres
Date limite
Aug 10, 2026

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration 24 MONTH
  • Supply of the pharmaceutical product Tocilizumab
  • Framework agreement with duration of 24 months (with possibility of up to 120 months as per XML notice)
Afficher le résumé complet

This is an open procedure for a framework agreement for the supply of Tocilizumab (a medicinal product) in Belgium. The tender is managed by Hospilim VZW, a public health undertaking. The contract duration is 24 months (with a possible extension of 120 months indicated in the XML notice). The submission deadline is 2026-08-10T08:00:00 UTC. The tender is not EU-funded according to the XML notice (no-eu-funds), though structured data says EU-funded. Estimated value is not provided. The procurement documents are available online but were not analyzed in detail.

Risques

The estimated contract value is not disclosed. This makes it hard to evaluate the financial opportunity and bid prepara...

The tender is only in Dutch (NLD). Non-Dutch speaking suppliers may struggle to understand requirements and submit comp...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Administrative

  • Electronic submission is required
  • Tender documents must be accessed via the provided URL
  • Language of tender: Dutch (NLD)

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

Cost criterion: Total net cost (weight 60, code per-exa) — 60%Quality criterion: Pharmaceutical quality and safety (weight 20, code per-exa) — 20%Quality criterion: Delivery reliability and after-sales service (weight 20, code per-exa) — 20%

Acheteur

Localisation

Diepenbeek, BEL

Profil acheteur

Ouvrir le profil

Identifiant

0833506251_1137

Activité

Health

Lots (1)

LOT-0001

Tocilizumab

Framework agreement for the supply of Tocilizumab. The lot covers pharmaceutical products with CPV codes 33600000, 33690000, and 33652000. Performance is in Belgian subdivisions BE223, BE224, BE225.

SuppliesFrameworkEU fundedElectronic submission

Localisation

BE223, Belgium

Durée

24 MONTH

Catégorie

Pharmaceutical products

Critères d'attribution

Quality

Date limite

Expired Aug 10, 2026

Détails de la procédure

Date de publication
25 Jun 2026
Langues
Dutch

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
441078-2026

Documents (2)

Appels d'offres similaires